April 18 Xoma Corp
* Xoma presents positive data from PTH1R monoclonal antibody program
* Xoma corp says PTH1R antagonism in vitro by anti-PTH1R MAB translated to potent in vivo activity Source text for Eikon: Further company coverage:
BRIEF-Changfeng Q1 earnings per share RMB0.17
* Changfeng announces first quarter financial results for the three months ended march 31, 2017
UPDATE 4-Key projects at risk as Greens back NDP in British Columbia
VANCOUVER, May 29 British Columbia's minority Green Party on Monday struck a deal with the left-leaning New Democrats to govern Canada's western-most province, a move that casts doubt on the future of key energy projects from firms such as Kinder Morgan Inc.